Suppr超能文献

立体定向放射外科在脑膜瘤和前庭神经鞘瘤中的作用。

Role of stereotactic radiosurgery in meningiomas and vestibular schwannomas.

机构信息

Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, MN, 55905, USA,

出版信息

Curr Treat Options Neurol. 2014 Aug;16(8):308. doi: 10.1007/s11940-014-0308-3.

Abstract

Intracranial meningiomas and vestibular schwannomas (VS, aka acoustic neuromas) are typically benign, slow-growing, non-invasive neoplasms. The imaging and radiobiologic characteristics of these tumors make them good candidates for stereotactic radiosurgery (SRS), a technique that has been in use for over three decades. Patient selection is critical for successful SRS: small- to moderate-sized tumors can be effectively treated with SRS if the patient does not have symptoms related to mass effect. Factors related to tumor control in meningioma SRS include histology, history of prior surgery, and volume. Tumor control rates after SRS is significantly lower for patients with WHO grade II or III meningiomas compared to patients with WHO grade I meningiomas. The risk of radiation-related complications is higher for patients with larger tumors and tumors located over the convexities or along the falx. Patients with small-volume non-operated skull base or tentorial WHO grade I meningiomas typically have the best outcomes after SRS. Radiosurgery of sporadic VS provides a high tumor control rate (92-95 %), with less than a 5 % risk of facial weakness. Hearing preservation progressively declines for 10 years or more after SRS, and the primary factors related to long-term preservation of useful hearing are tumor size and pre-SRS hearing class. Radiosurgery remains an important option for patients with neurofibromatosis type 2, but tumor control is lower and the risk of cranial nerve deficits is greater when compared to patients with sporadic VS.

摘要

颅内脑膜瘤和前庭神经鞘瘤(VS,又称听神经瘤)通常是良性、生长缓慢、非侵袭性的肿瘤。这些肿瘤的影像学和放射生物学特征使它们成为立体定向放射外科(SRS)的良好候选者,该技术已经使用了三十多年。患者选择对于 SRS 的成功至关重要:如果患者没有与肿块效应相关的症状,小到中等大小的肿瘤可以通过 SRS 有效治疗。脑膜瘤 SRS 中与肿瘤控制相关的因素包括组织学、既往手术史和肿瘤体积。与 WHO 分级 I 脑膜瘤患者相比,WHO 分级 II 或 III 脑膜瘤患者 SRS 后的肿瘤控制率明显较低。对于体积较大的肿瘤和位于凸面或沿镰旁的肿瘤,辐射相关并发症的风险更高。未手术的颅底或天幕 WHO 分级 I 脑膜瘤体积较小的患者通常在 SRS 后获得最佳结果。散发性 VS 的放射外科提供了较高的肿瘤控制率(92-95%),面神经无力的风险小于 5%。SRS 后 10 年或更长时间,听力保存逐渐下降,与长期保留有用听力相关的主要因素是肿瘤大小和 SRS 前听力分级。对于神经纤维瘤病 2 型患者,放射外科仍然是一个重要的选择,但与散发性 VS 患者相比,肿瘤控制率较低,颅神经损伤的风险更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验